Philips Respironics Settlement Results in $24.8M Payment To Resolve Kickback Claims
The DOJ has reached a settlement agreement requiring Philips Respironics to pay more than $24 million to resolve illegal kickback allegations.
The DOJ has reached a settlement agreement requiring Philips Respironics to pay more than $24 million to resolve illegal kickback allegations.
Bayer has agreed to pay $40 million to resolve a whistleblower lawsuit which accused it of kickback schemes and off-label marketing of the drugs Avelox, Baycol and Trasylol.
Mallinckrodt will pay $260 million to resolve illegal Medicaid fraud and kickback claims brought against it by whistleblowers and the federal government over its marketing of Acthar gel.
The NHTSA has handed out its first whistleblower compensation to an employee who revealed safety violations by Hyundai and Kia, leading to millions of vehicles being recalled due to engine…
St. Jude will pay the Justice Department $27 million to settle a whistleblower claim that it lied to the FDA about the safety of several of its implantable defibrillators, which…
The Justice Department says it recovered nearly $3 billion in fraud claims last year, mostly from healthcare fraud, thanks in large part to whistleblowers.
A whistleblower lawsuit has resulted in Johnson & Johnson subsidiary Acclarent paying $18 million to settle federal claims that it illegally marketed a drug delivery system without FDA approval.
A False Claims Act lawsuit against Wyeth, a unit of Pfizer, over Protonix discounts it failed to disclose, has resulted in a $784.6 million settlement.
A whistleblower who wore a wire to help investigators discover Johnson & Johnson's illegal Risperdal marketing will be awarded nearly $30 million.
The government will share $168 million of the $2.2 billion it collected from Johnson & Johnson over illegal marketing of Risperdal with whistleblowers who clued the government in on the…